| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Divisions of Human Biology [M. T. B., B. J. R., P. S. R.] and Public Health Sciences [B. J. R.], Fred Hutchinson Cancer Research Center, Seattle, Washington 98104; LifeSpan Biosciences, Seattle, Washington 98121 [D. P.]; and Departments of Medicine (Gastroenterology Division) [B. J. R.], Pathology [C. P-W., J. A., P. S. R.], and Genetics [B. J. R.], University of Washington, Seattle, Washington 98195
Elevated 4N (G2-tetraploid) cell populations are unstable intermediates in the development of many human cancers. However, 4N cell populations are intermixed with larger diploid fractions in vivo, limiting investigation of these key intermediates of neoplastic progression. Therefore, to study elevated 4N cell populations in human neoplasia, we used flow cytometry to purify populations of spontaneously arising TP53wt and TP53mut 4N cells from cell strains derived from premalignant Barretts esophagus biopsies. Using oligonucleotide arrays, we identified 625 genes differentially expressed in at least one replicate 2N/4N comparison in each strain and in hTERT-immortalized cultures of the TP53mut strains. Strikingly, when hierarchically clustered, these data contained a large node of 124 genes that were up-regulated in 4N TP53mut cells in the absence of condensed chromosomes. Most of these genes function in G2-M to mediate processes such as chromosome condensation and segregation. These results describe the molecular phenotype of dysregulated G2-M functions and cell cycle checkpoints in a key intermediate of human neoplastic progression.
This article has been cited by other articles:
![]() |
Z. Storchova and C. Kuffer The consequences of tetraploidy and aneuploidy J. Cell Sci., December 1, 2008; 121(23): 3859 - 3866. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Chao, C. A. Sanchez, P. C. Galipeau, P. L. Blount, T. G. Paulson, D. S. Cowan, K. Ayub, R. D. Odze, P. S. Rabinovitch, and B. J. Reid Cell Proliferation, Cell Cycle Abnormalities, and Cancer Outcome in Patients with Barrett's Esophagus: A Long-term Prospective Study Clin. Cancer Res., November 1, 2008; 14(21): 6988 - 6995. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Milyavsky, Y. Tabach, I. Shats, N. Erez, Y. Cohen, X. Tang, M. Kalis, I. Kogan, Y. Buganim, N. Goldfinger, et al. Transcriptional Programs following Genetic Alterations in p53, INK4A, and H-Ras Genes along Defined Stages of Malignant Transformation Cancer Res., June 1, 2005; 65(11): 4530 - 4543. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Helm, S. A. Enkemann, D. Coppola, J. S. Barthel, S. T. Kelley, and T. J. Yeatman Dedifferentiation Precedes Invasion in the Progression from Barrett's Metaplasia to Esophageal Adenocarcinoma Clin. Cancer Res., April 1, 2005; 11(7): 2478 - 2485. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pohler, A. L. Craig, J. Cotton, L. Lawrie, J. F. Dillon, P. Ross, N. Kernohan, and T. R. Hupp The Barrett's Antigen Anterior Gradient-2 Silences the p53 Transcriptional Response to DNA Damage Mol. Cell. Proteomics, June 1, 2004; 3(6): 534 - 547. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Sabichi, M.-F. Demierre, E. T. Hawk, C. E. Lerman, and S. M. Lippman Frontiers in Cancer Prevention Research Cancer Res., September 15, 2003; 63(18): 5649 - 5655. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |